Predict your next investment

Venture Capital
1984.vc

See what CB Insights has to offer

Investments

22

Funds

4

About 1984 Ventures

1984 Ventures is a San Francisco-based venture capital firm.

1984 Ventures Headquarter Location

44 Tehama Street

San Francisco, California, 94105,

United States

408-420-9220

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest 1984 Ventures News

CareSignal Raises Funding From OSF Ventures, UnityPoint Health, Nueterra Capital, And 1984 Ventures

Feb 20, 2020

CareSignal announced investments from 4 strategically aligned healthcare technology venture capital funds CareSignal (previously known as Epharmix) announced investments from 4 strategically aligned healthcare technology venture capital funds. CareSignal is an accessible remote patient monitoring platform that improves payer and provider performance in value-based care as it engages and identifies rising-risk patients. And two of the investors — OSF Ventures and UnityPoint Health Ventures — are customer-partners that use CareSignal remote patient monitoring and engagement solutions. Plus OSF Ventures is expanding on a previous investment in CareSignal. Nueterra Capital and 1984 Ventures provide a combination of deep technology experience, ties to national healthcare ecosystems, and healthcare operations expertise. “These investors represent the best-possible capital partners for CareSignal,” said Blake Marggraff, CEO and co-founder of CareSignal. “We’re actively deploying the additional funding toward sales and marketing as we expand nationally to new payer and large provider partners. The expertise, connections and capital from OSF, UnityPoint, Nueterra and 1984 are enabling CareSignal to grow even faster and impact the healthcare stakeholders—customers and patients alike—that have the most to gain.” ADVERTISEMENT OSF Ventures director of venture investments Mayank Taneja pointed out that the venture firm is pleased to continue its financial support of CareSignal. “As a pioneer in adoption of patient-centric innovative solutions, OSF HealthCare is proud to be a growing customer and partner of the company. Their technology enhances our ability to communicate with our patients and react to their needs. Improved patient outcomes along with a compelling value proposition make this a solution of choice for us,” added Taneja. Clint Myers, vice president of Nueterra Capital, pointed out that his venture firm has deep experience in healthcare administration, value-oriented health innovations, and digital health startups. “Nueterra chose to invest in CareSignal because of the company’s traction with evidence-based solutions adopted by systems across the nation; technology, including defensible intellectual property and an aggressive focus on machine learning; and timing, as the industry shifts to true value-based care,” explained Myers. 1984 Ventures general partner Ramy Adeeb said that his firm focuses on companies using software to solve real-world problems at scale and they could not be more excited about their investment in CareSignal. “By using technology to prioritize and engage with rising-risk patients in real-time, CareSignal is able to improve outcomes and reduce cost in some of healthcare’s most challenging and expensive areas, including heart failure, hypertension, and diabetes,” stated Farzad Soleimani, MD, MBA, healthcare partner at 1984 Ventures.

1984 Ventures Investments

22 Investments

1984 Ventures has made 22 investments. Their latest investment was in Vizion as part of their Seed VC - II on August 8, 2021.

CBI Logo

1984 Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/26/2021

Seed VC - II

Vizion

$3.25M

Yes

Ashish Mistry, Dynamo VC, MS&AD Ventures, Revolution Rise Of The Rest Seed Fund, SaaS Venture Capital, Tech Square Ventures, and Wavemaker Partners

3

7/21/2021

Series B

Properly

$34.7M

Yes

AlleyCorp, Bain Capital, Eric Wu, FJ Labs, Frasers Property, Golden Ventures, Intact Ventures, Interplay Ventures, Max Ventures, Mike Katchen, Prudence Holdings, and Spencer Rascoff

1

6/22/2021

Bridge

Dovly

$3M

Yes

Croghan Investments, Fawkes Global, and NFX

4

5/13/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

3/18/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/26/2021

7/21/2021

6/22/2021

5/13/2021

3/18/2021

Round

Seed VC - II

Series B

Bridge

Seed VC - II

Series B

Company

Vizion

Properly

Dovly

Subscribe to see more

Subscribe to see more

Amount

$3.25M

$34.7M

$3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Ashish Mistry, Dynamo VC, MS&AD Ventures, Revolution Rise Of The Rest Seed Fund, SaaS Venture Capital, Tech Square Ventures, and Wavemaker Partners

AlleyCorp, Bain Capital, Eric Wu, FJ Labs, Frasers Property, Golden Ventures, Intact Ventures, Interplay Ventures, Max Ventures, Mike Katchen, Prudence Holdings, and Spencer Rascoff

Croghan Investments, Fawkes Global, and NFX

Sources

3

1

4

10

10

1984 Ventures Fund History

4 Fund Histories

1984 Ventures has 4 funds, including 1984 Ventures Master Series - Gaudi I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/10/2020

1984 Ventures Master Series - Gaudi I

$0.57M

1

11/9/2018

1984 Ventures

Subscribe to see more

$99M

10

1984 Ventures Master Series - Gaudi II

Subscribe to see more

$99M

10

1984 Ventures II

Subscribe to see more

$99M

10

Closing Date

3/10/2020

11/9/2018

Fund

1984 Ventures Master Series - Gaudi I

1984 Ventures

1984 Ventures Master Series - Gaudi II

1984 Ventures II

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$0.57M

$99M

$99M

$99M

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.